Stay updated with breaking news from Breakthrough Device Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the first quarter ended March...
Conference call to discuss financial and operational results scheduled for Thursday, March 16, at 8:30 a.m. U.S. Eastern Time Executed global licensing and...
GOTHENBURG, SE / ACCESSWIRE / September 20, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)
Spectral Announces Second Quarter 2022 Results and Provides Corporate Update - read this article along with other careers information, tips and advice on BioSpace
TORONTO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing...